Good morning. Happy Tuesday.
The Asian/Pacific markets closed mostly up. Japan, China, India, Malaysia, Indonesia, Singapore, Thailand and the Philippines did the best; New Zealand and Australia posted losses. Europe, Africa and the Middle East are currently doing very well. Denmark, Poland, Germany, the UAE, Greece, Finland, Norway, Austria, Saudi Arabia and the Czech Republic are leading; Turkey is down. Futures in the States point towards a positive open for the cash market.
The dollar is up. Oil is up; copper is down. Gold and silver are down. Bonds are mixed.
Overnight Stock Movers from barchart.com…
Weight Watchers International (WTW -4.49%) was rated a new ‘Overweight’ at KeyBanc Capital Markets with a price target of $115.
JPMorgan Chase (JPM +3.09%) was upgraded to ‘Strong Buy’ from ‘Outperform’ at Vining Sparks with a price target of $125.
Carnival (CCL +0.68%) fell 2% in pre-market trading after Goldman Sachs cut the company’s earnings estimates citing “incremental fuel/FX headwinds offsetting ongoing demand strength.”
Wynn Resorts Ltd (WYNN +2.08%) was upgraded to ‘Buy’ from ‘Hold’ at Stifel with a price target of $207.
Cboe Global Markets (CBOE +2.40%) was rated a new ‘Buy’ at Compass Point with a price target of $115.
Cerner (CERN +1.19%) was downgraded to ‘Underperform’ from ‘In-line’ at Evercore ISI with a price target of $55.
Northern Trust (NTRS +2.92%) was upgraded to ‘Strong Buy’ from ‘Outperform’ at Vining Sparks with a price target of $125.
Inspire Medical Systems (INSP -0.38%) jumped 7% in after-hours trading after it said Aetna will provide coverage for its Inspire therapy for patients with obstructive sleep apnea, effective immediately.
Cactus (WHD +4.46%) fell 4% in after-hours trading after it filed to sell 10 million shares of its stock via Citigroup and Credit Suisse.
Southern Co (SO -2.91%) was rated ‘Overweight’ at Barclays with a price target of $51.
Capstead Mortgage (CMO -0.32%) was downgraded to ‘Market Perform’ from ‘Outperform’ at Keefe, Bruyette & Woods with a price target of $9.
American Renal Associates Holdings (ARA +2.61%) gained more than 3% in after-hours trading after it reached a settlement with and will enter into a 3-year network agreement with UnitedHealthcare effective August 1, 2018.
Spero Therapeutics (SPRO +2.96%) fell more than 4% in after-hours trading after it announced that it had commenced an underwritten public offering of 4.5 million shares of its common stock.
OncoCyte (OCX +3.39%) soared more than 55% in after-hours trading after it reported the company’s most recent study of clinical samples in the development of its DertermaVu, its lung cancer diagnostic blood test, has produced encouraging results.
Today’s Economic Calendar
6:00 NFIB Small Business Optimism Index
8:55 Redbook Chain Store Sales
10:00 Labor market condition index
1:00 PM Results of $33B, 3-Year Note Auction
Other…
today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY